Transdermal compositions comprising cannabidiol (CBD) for use in the treatment of seizure disorders
The preparation of transdermal pharmaceutical compositions comprising cannabidiol (CBD) and use thereof in the treatment of seizure disorders is disclosed. Preferably, the CBD is provided in the form of a highly purified extract of cannabis that comprises at least 90 % (w/w) of cannabidiol. The tran...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LATHER, Tamanna PLAKOGIANNIS, Fotios BOROVINSKAYA, Marina MODI, Nisarg |
| description | The preparation of transdermal pharmaceutical compositions comprising cannabidiol (CBD) and use thereof in the treatment of seizure disorders is disclosed. Preferably, the CBD is provided in the form of a highly purified extract of cannabis that comprises at least 90 % (w/w) of cannabidiol. The transdermal compositions may take a number of different forms and incorporate various different excipients (such as propylene glycol and hexylene glycol). The seizure disorders treated include various types of treatment resistant epilepsy (TRE). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2020361741BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2020361741BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2020361741BB23</originalsourceid><addsrcrecordid>eNqNjDEKwlAMQLs4iHqHDA46CG0VnW1VPECdS_xNNdAmJfldPL0iHsDp8eDxpkmoDMUbsh47CNoP6hxZxb9i7CwPCCiCd25YO1iVxWkNrRqMTsAC8UkQjTD2JBG0BSd-jUbQsKt9zj5PJi12TosfZ8nycq7K64YGrckHDCQU6-MtT_N0u88Ou6wo8u2f2RsWWz-w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Transdermal compositions comprising cannabidiol (CBD) for use in the treatment of seizure disorders</title><source>esp@cenet</source><creator>LATHER, Tamanna ; PLAKOGIANNIS, Fotios ; BOROVINSKAYA, Marina ; MODI, Nisarg</creator><creatorcontrib>LATHER, Tamanna ; PLAKOGIANNIS, Fotios ; BOROVINSKAYA, Marina ; MODI, Nisarg</creatorcontrib><description>The preparation of transdermal pharmaceutical compositions comprising cannabidiol (CBD) and use thereof in the treatment of seizure disorders is disclosed. Preferably, the CBD is provided in the form of a highly purified extract of cannabis that comprises at least 90 % (w/w) of cannabidiol. The transdermal compositions may take a number of different forms and incorporate various different excipients (such as propylene glycol and hexylene glycol). The seizure disorders treated include various types of treatment resistant epilepsy (TRE).</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240905&DB=EPODOC&CC=AU&NR=2020361741B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240905&DB=EPODOC&CC=AU&NR=2020361741B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LATHER, Tamanna</creatorcontrib><creatorcontrib>PLAKOGIANNIS, Fotios</creatorcontrib><creatorcontrib>BOROVINSKAYA, Marina</creatorcontrib><creatorcontrib>MODI, Nisarg</creatorcontrib><title>Transdermal compositions comprising cannabidiol (CBD) for use in the treatment of seizure disorders</title><description>The preparation of transdermal pharmaceutical compositions comprising cannabidiol (CBD) and use thereof in the treatment of seizure disorders is disclosed. Preferably, the CBD is provided in the form of a highly purified extract of cannabis that comprises at least 90 % (w/w) of cannabidiol. The transdermal compositions may take a number of different forms and incorporate various different excipients (such as propylene glycol and hexylene glycol). The seizure disorders treated include various types of treatment resistant epilepsy (TRE).</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</subject><subject>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</subject><subject>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKwlAMQLs4iHqHDA46CG0VnW1VPECdS_xNNdAmJfldPL0iHsDp8eDxpkmoDMUbsh47CNoP6hxZxb9i7CwPCCiCd25YO1iVxWkNrRqMTsAC8UkQjTD2JBG0BSd-jUbQsKt9zj5PJi12TosfZ8nycq7K64YGrckHDCQU6-MtT_N0u88Ou6wo8u2f2RsWWz-w</recordid><startdate>20240905</startdate><enddate>20240905</enddate><creator>LATHER, Tamanna</creator><creator>PLAKOGIANNIS, Fotios</creator><creator>BOROVINSKAYA, Marina</creator><creator>MODI, Nisarg</creator><scope>EVB</scope></search><sort><creationdate>20240905</creationdate><title>Transdermal compositions comprising cannabidiol (CBD) for use in the treatment of seizure disorders</title><author>LATHER, Tamanna ; PLAKOGIANNIS, Fotios ; BOROVINSKAYA, Marina ; MODI, Nisarg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2020361741BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</topic><topic>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</topic><topic>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LATHER, Tamanna</creatorcontrib><creatorcontrib>PLAKOGIANNIS, Fotios</creatorcontrib><creatorcontrib>BOROVINSKAYA, Marina</creatorcontrib><creatorcontrib>MODI, Nisarg</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LATHER, Tamanna</au><au>PLAKOGIANNIS, Fotios</au><au>BOROVINSKAYA, Marina</au><au>MODI, Nisarg</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Transdermal compositions comprising cannabidiol (CBD) for use in the treatment of seizure disorders</title><date>2024-09-05</date><risdate>2024</risdate><abstract>The preparation of transdermal pharmaceutical compositions comprising cannabidiol (CBD) and use thereof in the treatment of seizure disorders is disclosed. Preferably, the CBD is provided in the form of a highly purified extract of cannabis that comprises at least 90 % (w/w) of cannabidiol. The transdermal compositions may take a number of different forms and incorporate various different excipients (such as propylene glycol and hexylene glycol). The seizure disorders treated include various types of treatment resistant epilepsy (TRE).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2020361741BB2 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Transdermal compositions comprising cannabidiol (CBD) for use in the treatment of seizure disorders |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T18%3A05%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LATHER,%20Tamanna&rft.date=2024-09-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2020361741BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |